Investor Type | Firm |
Industries | BioTech • Life Science |
Investing | United States |
Investment Range | $215,000,000 - $215,000,000 |
Bracebridge Capital is a Boston-based hedge fund manager focused on delivering absolute return strategies to a diversified investor base. Founded in 1994, the firm is distinguished by its innovative and entrepreneurial culture. Bracebridge Capital invests in distressed securities, fixed income, and public equity markets with a particular interest in the healthcare and life science sectors. As an employee-owned hedge fund sponsor, they apply meticulous risk analysis to pursue strategic investment opportunities and maintain a commitment to generating uncorrelated returns. The firm boasts an investment ethos that emphasizes long-term partnerships, trust, and aligned interests with their investors. With both investment minima and maxima set at $215,000,000, Bracebridge Capital operates with a high degree of selectivity and precision. Their team prides itself on collaboration, leveraging collective intelligence to underpin their investment process, and they prioritize curiosity and mentorship as critical components of their approach. Operational excellence and innovation are cited as drivers of their success, while they also benefit from the collaboration of a dedicated and dynamic team of professionals who are both smart and driven to achieve the firm's strategic goals. Bracebridge Capital's website emphasizes their core values, which include a dedication to absolute returns, strategic risk analysis, and fostering a collaborative, creative work environment that values employee contribution and teamwork.